Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sonendo-inc" target="_blank" data-smartkarma-citation="entities:34589:1" rel="noopener">Sonendo (SONX US) </a>shares debuted on the New York Stock Exchange on October 29, 2021. Shares are currently trading below the IPO price. Sonendo priced its $84 million IPO at $12 per share, well below the earlier announced range of $15–17.</li>
<li>Sonendo’s GentleWave system is an innovative technology for endodontic treatment, commonly known as root canal therapy. Increasing installed base of GentleWave consoles and their corresponding recurring utilization are generating a stream of predictable, recurring revenue from single-use procedure instrument.</li>
<li>Business scale up and expansion of marketing team will drive the long-term growth potential of the company.</li>
</ul>



Sonendo (SONX US) shares debuted on the New York Stock Exchange on October 29, 2021. Shares are currently trading below the IPO price. Sonendo priced its $84 million IPO at $12 per share, well below the earlier announced range of $15–17.
Sonendo’s GentleWave system is an innovative technology for endodontic treatment, commonly known as root canal therapy. Increasing installed base of GentleWave consoles and their corresponding recurring utilization are generating a stream of predictable, recurring revenue from single-use procedure instrument.
Business scale up and expansion of marketing team will drive the long-term growth potential of the company.


Sonendo (SONX US) IPO Review: Innovative Technology Platform, But Execution Is the Key